Impact Stories | McMaster University

McMaster researchers are leading a pan-Canadian study investigating the immune response to the COVID-19 vaccine within the South Asian community....

A team of virologists, infectious disease experts and immunologists at McMaster is developing two new second-generation COVID-19 vaccine candidates, designing and producing them in a specialized facility on campus....

Two Canadian powerhouses in infectious disease research have joined forces in the fight against COVID–19, leading Canada’s response and preparedness for future pandemics....

To ensure decision-makers have access to the best COVID-19 science in a timely manner, the federal government is investing $1 million to support the COVID-19 Evidence Network to support Decision-makers (COVID-END) hosted at McMaster University....

Last year when a multidisciplinary team of McMaster researchers created a viable new vaccine-delivery platform that does not rely on refrigeration, they hoped it might help get life-saving vaccines to remote locations....

Researchers at McMaster University are studying the saliva-based testing procedures that would enable routine testing of asymptomatic individuals on a large scale....

An innovative virtual incubator created by an entrepreneurship expert from the DeGroote School of Business is helping women whose careers have suffered during the pandemic turn their skills to community-minded entrepreneurship....

When COVID-19 attacks, the immune system produces a cytokine, or protein, called Interleukin-6 (IL-6), whose concentrations can offer vital information about a patient’s level and stage of infection....

McMaster University professor emeritus Frank Graham has been recognized for the impact of his scientific work almost five decades ago which is being used for production of several COVID-19 vaccine candidates....

As provinces across Canada are deciding how to restart schools during the pandemic, a research review has found children are not a major source of transmission of COVID-19....